Vesalius Biocapital offers venture capital
to young European innovative life science companies
Fei Tian holds a MD (Medical Doctor) degree (2008) from Shanghai Tongji University, People’s Republic of China. She began her career as a physician in emergency medicine. During her work as a physician, she also performed research in atherosclerosis and immunology. She pursued her interest in pulmonary oncology research for her scientific doctoral degree for a PhD at the Ludwig-Maximilian University and Thoracic Oncology Center, Munich, Germany. She has several publications as author and co-author in international peer-reviewed journals.
In addition to her medical and scientific research background, she gained substantial experience of medical communication and life science consulting, including in-licensing of biological products, international market research and communication, and development of business strategies for global medtech companies and pharmaceutical companies.
Fei Tian joined Vesalius Biocapital as an analyst in 2012.